Sun Pharmaceutical Industries Limited
₹1,737-2.73%Feb 27, 3:45 PM IST
SUNPHARMA•Health Technology•Pharmaceuticals: Major
Current Price
₹1,737-2.73%
Feb 27, 3:45 PM ISTMarket Cap₹4,28,175.25 Cr
Market Cap₹4,28,175.25 Cr
Business Overview
Sun Pharmaceutical Industries Limited operates through 6 main business divisions including US Business, India Business, Emerging Markets, Global Specialty, Global Consumer Healthcare, API (Active Pharmaceutical Ingredients).
Business Hierarchy Structure for Sun Pharmaceutical Industries Limited
- Sun Pharmaceutical Industries Limited
- US Business
- Specialty Medicines
- Dermatology
- Ophthalmology
- Onco-dermatology
- Ilumya/Ilumetri
- Winlevi
- Cequa
- Odomzo
- Levulan Kerastick+BLU-U
- Deuruxolitinib (Pipeline)
- NidlegyTM (Pipeline)
- MM-II (Pipeline)
- SCD-044 (Pipeline)
- GLP-1R agonist (Pipeline)
- Generics and Branded Generic Medicines
- Tablets
- Capsules
- Injectables
- Inhalers
- Ointments
- Creams
- Liquids
- Over the Counter (OTC) Medicines
- Medications for cough, sore throat
- Vitamins
- Topical analgesics
- Cold & flu remedies
- Analgesics
- Lifestyle products
- Digestives
- Active Pharmaceutical Ingredients (APIs)
- Specialty Medicines
- India Business
- Specialty Medicines
- Dermatology
- Ophthalmology
- Onco-dermatology
- Cequa (launched in India)
- Tyvalzi (for ischemic stroke)
- Rytstat (for anemia)
- Lyvelsa (for kidney failure)
- Generics and Branded Generic Medicines
- Tablets
- Capsules
- Injectables
- Inhalers
- Ointments
- Creams
- Liquids
- Over the Counter (OTC) Medicines
- Volini
- Revital H
- Abzorb
- Revital Cal 500
- Active Pharmaceutical Ingredients (APIs)
- Specialty Medicines
- Emerging Markets
- Specialty Medicines
- Dermatology
- Ophthalmology
- Onco-dermatology
- Generics and Branded Generic Medicines
- Tablets
- Capsules
- Injectables
- Inhalers
- Ointments
- Creams
- Liquids
- Over the Counter (OTC) Medicines
- Medications for cough, sore throat
- Vitamins
- Topical analgesics
- Cold & flu remedies
- Analgesics
- Lifestyle products
- Digestives
- Active Pharmaceutical Ingredients (APIs)
- Specialty Medicines
- Global Specialty
- Dermatology
- Ophthalmology
- Onco-dermatology
- Ilumya/Ilumetri
- Winlevi
- Cequa
- Odomzo
- Levulan Kerastick+BLU-U
- Deuruxolitinib (Pipeline)
- NidlegyTM (Pipeline)
- MM-II (Pipeline)
- SCD-044 (Pipeline)
- GLP-1R agonist (Pipeline)
- Global Consumer Healthcare
- Volini
- Revital H
- Abzorb
- Revital Cal 500
- API (Active Pharmaceutical Ingredients)
- APIs for complex formulations
- US Business